IRIS
BOSSI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 759
NA - Nord America 341
EU - Europa 77
SA - Sud America 6
AF - Africa 2
Totale 1.185
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 542
US - Stati Uniti d'America 340
CN - Cina 196
IT - Italia 37
DE - Germania 15
IN - India 7
BR - Brasile 6
FI - Finlandia 6
HK - Hong Kong 6
IE - Irlanda 6
ES - Italia 4
PK - Pakistan 4
GB - Regno Unito 3
HU - Ungheria 2
VN - Vietnam 2
AT - Austria 1
CA - Canada 1
DZ - Algeria 1
MY - Malesia 1
NG - Nigeria 1
NL - Olanda 1
PL - Polonia 1
SE - Svezia 1
TH - Thailandia 1
Totale 1.185
Salva come PNG Salva come JPEG
Città #
Singapore 338
Shanghai 184
Seattle 80
Boardman 25
Chandler 12
Santa Clara 12
Milan 8
Munich 8
Dublin 6
Genoa 6
Helsinki 6
Hong Kong 6
São Paulo 5
Wilmington 5
Naples 4
San Mateo 4
Bengaluru 3
Brescia 3
Karachi 3
Ann Arbor 2
Barcelona 2
Catania 2
Chengdu 2
Hanoi 2
Lawrence 2
London 2
New Delhi 2
Nuremberg 2
Padova 2
Palermo 2
Pamplona 2
Princeton 2
Putnam Valley 2
Rome 2
Springfield 2
Suzhou 2
Szeged 2
Amsterdam 1
Ashburn 1
Benin City 1
Charlotte 1
Constantine 1
Falkenstein 1
Fort Worth 1
Leawood 1
Manaus 1
Mercogliano 1
Oakland 1
Ottawa 1
Secaucus 1
Subang Jaya 1
Vienna 1
Woodbridge 1
Totale 770
Salva come PNG Salva come JPEG
Nome #
Role of Radiotherapy in the management of metastases from salivary gland carcinoma. 39
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 21
Precision medicine in head and neck cancer: from immunotherapy to microbiota, circulating DNA and robotic surgery 12
Understanding Protective Mechanisms of an Oral Probiotic in Reducing Radiation-Induced Oral Mucositis 9
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers 9
The Case Volume Issue in Head and Neck Oncology 8
Meta-analysis of cardiovascular toxicity risks in cancer patients on selected targeted agents 8
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma 8
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements 8
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN) 8
Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis 8
A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes 8
ESMO Guidelines: Cancer patient management during the COVID-19 pandemic 8
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 7
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma 7
Timing of chemoradiotherapy and patient selection for locally advanced nasopharyngeal carcinoma 7
A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1] 7
Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy 7
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial 7
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic 7
Advanced Cutaneous Squamous Cell Carcinoma Management in Immunotherapy Era: Achievements and New Challenges 7
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 7
Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach, part II: radiation technique and fractionations 7
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents 7
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck 6
Estimating survival after salvage surgery for recurrent salivary gland cancers: Systematic review 6
Advances in the changing patterns of aetiology of head and neck cancers 6
Sinonasal Malignancies of Anterior Skull Base Histology-driven Treatment Strategies 6
The European Network for Sinonasal Cancer Research (EUSICA) – A pan-European initiative targeting a group of orphan tumours 6
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy 6
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach 6
Stability of circulating miRNA in saliva: The influence of sample associated pre-analytical variables 6
Guidance on mucositis assessment from the MASCC Mucositis Study Group and ISOO: an international Delphi study 6
Eliciting Preferences for Clinical Follow-Up in Patients with Head and Neck Cancer Using Best-Worst Scaling 6
Acquired resistance to Hedgehog inhibitor through smoothened mutation in basal cell carcinoma 6
Computer Vision Foundation Models in Endoscopy: Proof of Concept in Oropharyngeal Cancer 6
The present and the future of benzydamine: expert opinion paper 6
The Use of Artificial Intelligence in Head and Neck Cancers: A Multidisciplinary Survey 6
A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancer 6
Blood Markers Predicting Clinically Occult Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma 6
A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab: An exploratory study 6
Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies? 5
Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients 5
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab 5
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life 5
Induction chemotherapy prior to surgery with or without postoperative radiotherapy for oral cavity cancer patients: Systematic review and meta-analysis 5
Comparison of different treatments for HPV+ oropharyngeal carcinoma: a network meta-analysis 5
Radiotherapy for unresectable sinonasal cancers: Dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapy 5
Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients 5
Immunotherapy for Nasopharyngeal Carcinoma 5
Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer 5
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 5
Malignant salivary gland tumours in families with breast cancer susceptibility 5
Why Oncologists Should Feel Directly Involved in Persuading Patients with Head and Neck Cancer to Quit Smoking 5
Cohort analysis of safety and efficacy of vismodegib in Italian patients from the Phase II, multicenter STEVIE study 5
Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients 5
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways 5
Treatment de-escalation for HPV+ oropharyngeal cancer: A systematic review and meta-analysis 5
Regional disease in head and neck cutaneous squamous cell carcinoma: the role of primary tumor characteristics and number of nodal metastases 5
Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm? 5
Is restoring platinum sensitivity the best goal for cetuximab in recurrent/metastatic nasopharyngeal cancer? [15] 5
Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma 5
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial 5
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune Disorders 5
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy 5
T-cell therapy for the control of EBV-related nasopharyngeal carcinoma 5
Is PSA useful in the diagnosis and monitoring of parotid adenocarcinomas? 5
Cost-effectiveness of Molecular Profile Patient Selection for First-line Treatment of Recurrent/Metastatic Head and Neck Cancer 5
A NATURAL HISTORY OF A SERIES OF RADIOACTIVE IODINE (131I-RAI)-RESISTANT ADVANCED DIFFERENTIATED THYROID CANCER (DTC) 5
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma 5
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study 5
Regionally advanced nasopharyngeal carcinoma: Long-term outcome after sequential chemotherapy and radiotherapy 5
The efficacy of immunonutrition in improving tolerance to chemoradiotherapy in patients with head and neck cancer, receiving nutritional counseling: study protocol of a randomized, open-label, parallel group, bicentric pilot study 5
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin 5
Primary resistances to EGFR inhibitors (EGFRi) in HPV-positive and -negative oropharyngeal squamous cell carcinoma (OSCC) 5
An environment for guideline-based decision support systems for outpatients monitoring 5
Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: An alternative approach for overcoming potential bias 5
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results 5
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma 5
Measuring financial toxicity in head and neck cancer: a systematic review 5
Expression of PDL-1 between primary and recurrent/metastatic head and neck squamous cell carcinoma: A bi-institutional retrospective concordance analysis (CONCORDL-1 study) 5
A multidisciplinary approach to squamous cell carcinomas of the head and neck: What is new? 5
Salvage surgery in recurrent sinonasal cancers: Proposal for a prognostic model based on clinicopathologic and treatment-related parameters 5
Treatment of cutaneous squamous cell carcinoma with immune checkpoint inhibitors in special populations 5
Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines 5
Head and neck tumors other than squamous cell carcinoma 5
A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy 5
Description of adverse events in publications of clinical trials: Much room for improvement 5
Association between salivary cytokine levels and chemoradiotherapy-induced toxicities in head and neck cancer patients 5
Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil (TPF) induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced nasopharyngeal cancer (LANPC) 5
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents 5
A nationwide survey among emergency physicians and oncologists to improve the management of immune checkpoint inhibitors toxicity 5
Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO) 5
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact 5
The 8th TNM classification for oral squamous cell carcinoma: What is gained, what is lost, and what is missing 5
Optimizing the treatment of nasopharyngeal cancer: Anupdate of the milan experience including imrt and chemotherapy intensification 5
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines 5
Quality Assessment in Supportive Care in Head and Neck Cancer 5
Relevance of apparent diffusion coefficient features for a radiomics-based prediction of response to induction chemotherapy in sinonasal cancer 5
A randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy of Aqualief™ mucoadhesive tablets in head and neck cancer patients who developed radiation-induced xerostomia 5
Totale 628
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.530
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 3 1 1 2 1 0 2
2021/20224 0 0 0 2 0 0 0 1 0 0 1 0
2022/202334 4 0 2 4 5 3 0 1 11 2 1 1
2023/20241.238 2 2 6 0 0 0 1 434 40 49 250 454
2024/2025321 130 25 56 84 26 0 0 0 0 0 0 0
Totale 1.607